KCM
Karp Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,640
| Closed | -$1.34M | – | 97 |
|
|
2022
Q3 | $1.34M | Sell |
2,640
-99
| -4% | -$50.2K | 0.27% | 69 |
|
|
2022
Q2 | $1.49M | Hold |
2,739
| – | – | 0.26% | 85 |
|
|
2022
Q1 | $1.62M | Sell |
2,739
-456
| -14% | -$269K | 0.24% | 78 |
|
|
2021
Q4 | $2.13M | Buy |
3,195
+17
| +0.5% | +$11.3K | 0.27% | 82 |
|
|
2021
Q3 | $1.82M | Hold |
3,178
| – | – | 0.26% | 87 |
|
|
2021
Q2 | $1.6M | Hold |
3,178
| – | – | 0.24% | 89 |
|
|
2021
Q1 | $1.45M | Sell |
3,178
-1,057
| -25% | -$482K | 0.26% | 78 |
|
|
2020
Q4 | $1.97M | Buy |
4,235
+200
| +5% | +$93.2K | 0.41% | 69 |
|
|
2020
Q3 | $1.78M | Buy |
4,035
+30
| +0.7% | +$13.2K | 0.44% | 64 |
|
|
2020
Q2 | $1.45M | Hold |
4,005
| – | – | 0.4% | 58 |
|
|
2020
Q1 | $1.14M | Sell |
4,005
-975
| -20% | -$277K | 0.37% | 62 |
|
|
2019
Q4 | $1.62M | Hold |
4,980
| – | – | 0.43% | 67 |
|
|
2019
Q3 | $1.45M | Buy |
4,980
+35
| +0.7% | +$10.2K | 0.42% | 66 |
|
|
2019
Q2 | $1.45M | Hold |
4,945
| – | – | 0.46% | 68 |
|
|
2019
Q1 | $1.35M | Sell |
4,945
-800
| -14% | -$219K | 0.48% | 69 |
|
|
2018
Q4 | $1.29M | Hold |
5,745
| – | – | 0.61% | 55 |
|
|
2018
Q3 | $1.4M | Sell |
5,745
-460
| -7% | -$112K | 0.48% | 72 |
|
|
2018
Q2 | $1.29M | Hold |
6,205
| – | – | 0.51% | 66 |
|
|
2018
Q1 | $1.28M | Sell |
6,205
-130
| -2% | -$26.8K | 0.52% | 64 |
|
|
2017
Q4 | $1.2M | Buy |
6,335
+210
| +3% | +$39.9K | 0.51% | 63 |
|
|
2017
Q3 | $1.16M | Sell |
6,125
-2,946
| -32% | -$557K | 0.54% | 59 |
|
|
2017
Q2 | $1.58M | Buy |
+9,071
| New | +$1.58M | 0.78% | 50 |
|
|
2015
Q4 | – | Sell |
-1,150
| Closed | -$141K | – | 269 |
|
|
2015
Q3 | $141K | Buy |
1,150
+300
| +35% | +$36.8K | 0.1% | 106 |
|
|
2015
Q2 | $110K | Sell |
850
-150
| -15% | -$19.4K | 0.07% | 121 |
|
|
2015
Q1 | $134K | Buy |
1,000
+475
| +90% | +$63.7K | 0.09% | 117 |
|
|
2014
Q4 | $66K | Buy |
+525
| New | +$66K | 0.05% | 150 |
|